Oncological treatment effect of head and neck cancer on auditory system
DOI:
https://doi.org/10.33448/rsd-v11i1.25209Keywords:
Head and neck neoplasms; Radiotherapy; Drug therapy; Haring loss.Abstract
Introduction: The improvement in the quality of life of patients with head and neck cancer has been the subject of studies, however hearing loss is one of the side effects of cancer treatment that significantly affect the quality of life of its patient, especially when radiotherapy is performed combined with cisplatin. Objective: To analyze the audiological findings of participants with head and neck cancer who underwent radiotherapy alone and concomitantly with cisplatin. Methodology: Participants with anatomopathological diagnosis of cancer of the head and neck who were at the end of cancer treatment, with normal hearing threshold prior to anticancer treatment, were included. Two groups were listed: Radiotherapy (RT) and chemotherapy concomitant with radiotherapy (QTRT). The QTRT participants used cisplatin, a drug from the Platinum Group at a dose between 200 and 300mg. Among the procedures performed are: anamnesis, otoscopy and conventional pure tone audiometry. Results: 22 subjects participated, with a mean age of 48.48 years, mostly men (68.2%). It was found that 59.1% had sensorineural hearing loss. The RT group consisted of 10 participants, 25% reported tinnitus and 38.5% were diagnosed with hearing loss. The QTRT with 12 participants reported tinnitus (25%) and 61.5% developed hearing loss. There was no statistically significant difference between groups for hearing thresholds in the frequencies under test. Conclusion: Patients undergoing antineoplastic treatment had significant side effects related to the hearing organ, and for treatment with concomitant chemotherapy and radiotherapy, the presence of hearing loss was significant.
References
Alvarenga, L. D. M., Ruiz, M. T., Pavarino-Bertelli, É. C., Ruback, M. J. C., Maniglia, J. V., & Goloni-Bertollo, E. M. (2008). Epidemiologic evaluation of head and neck patients in a university hospital of Northwestern São Paulo State. Braz.J Otorhinolaryngol. 74(1), 68–73.
Bhandare, N., Antonelli, P. J., Morris, C. G., Malayapa, R. S., & Mendenhall, W. M. (2007). Ototoxicity after radiotherapy for head and neck tumors. Int J Rad Oncol Biol Physics, 67(2), 469–479.
Brown, A., Kumar, S., & Tchounwou, P. B. (2019). Cisplatin-Based Chemotherapy of Human Cancers. J Cancer Sci Therapy, 11(4),97.
Cheraghi, S., Nikoofar, P., Fadavi, P., Bakhshandeh, M., Khoie, S., Gharehbagh, E. J., Farahani, S., Mohebbi, A., Vasheghani, M., Zare, M., Nikoofar, A., & Mahdavi, S. R. M. (2015). Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy. Med Oncol, 32(7),200.
Cohen, N., Fedewa, S., & Chen, A. Y. (2018). Epidemiology and Demographics of the Head and Neck Cancer Population. Oral Maxillofac Surg Clin North America, 30(4), 381–395.
Da Silva, F. A., Roussenq, S. C., Gonçalves de Souza Tavares, M., Pezzi Franco de Souza, C., Barreto Mozzini, C., Benetti, M., & Dias, M. (2020). Perfil Epidemiológico dos Pacientes com Câncer de Cabeça e Pescoço em um Centro Oncológico no Sul do Brasil. Rev Brasil Cancerol, 66(1), 302–308.
Dellaringa, A. H. B., de Lima Isaac, M., Arruda, G. V., DellAringa, A. R., & Esteves, M. C. B. N. (2010). Audiological findings in pacients treated with radiotherapy for head and neck tumors. Braz J Otorhinolaryngol, 76(4), 527–532.
Estimativa 2020 : incidência de câncer no Brasil / Instituto Nacional de Câncer José Alencar Gomes da Silva. – Rio de Janeiro : INCA, 2019. (n.d.).
Faria, S. de O., Nascimento, M. C. do, & Kulcsar, M. A. V. (2020). Malignant neoplasms of the oral cavity and oropharynx treated in Brazil: what do hospital cancer records reveal? Braz Otorhinolaryngol, S1808-8694(20), 30089
Frisina, R. D., Wheeler, H. E., Fossa, S. D., Kerns, S. L., Fung, C., Sesso, H. D., Monahan, P. O., Feldman, D. R., Hamilton, R., Vaughn, D. J., Beard, C. J., Budnick, A., Johnson, E. M., Ardeshir-Rouhani-fard, S., Einhorn, L. H., Lipshultz, S. E., Dolan, M. E., & Travis, L. B. (2016). Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J Clin Oncol, 34(23), 2712–2720.
Furness, S., Glenny, A. M., Worthington, H. V., Pavitt, S., Oliver, R., Clarkson, J. E., Macluskey, M., Chan, K. K., Conway, D. I., & CSROC Expert Panel, U. (2010). Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane database of systematic reviews (Online : Update Software), 9(9), CD006386.
Gibrin, P. C. D., Ciquinato, D. S. de A., Gonçalves, I. C., Marchiori, V. de M., & Marchiori, L. L. de M. (2019). Tinnitus and its relationship with anxiety and depression in the elderly: a systematic review. Rev CEFAC, 21(4),e7918.
Jereczek-Fossa, B. A., Zarowski, A., Milani, F., & Orecchia, R. (2003). Radiotherapy-induced ear toxicity. Cancer Treat Rev, 29(5), 417–430.
Khrunin, A. V., Moisseev, A., Gorbunova, V., & Limborska, S. (2010). Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients. Pharmacogen J 10(1), 54–61.
Kowalski, L. P., de Oliveira, M. M., Lopez, R. V. M., E Silva, D. R. M., Ikeda, M. K., & Curado, M. P. (2020). Survival trends of patients with oral and oropha-ryngeal cancer treated at a cancer center in são paulo, Brazil. Clinics, 75(4),e1507.
Landier, W. (2016). Ototoxicity and cancer therapy. Cancer, 122(11), 1647–1658.
Leoncini, E., Ricciardi, W., Cadoni, G., Arzani, D., Petrelli, L., Paludetti, G., Brennan, P., Luce, D., Stucker, I., Matsuo, K., Talamini, R., La Vecchia, C., Olshan, A. F., Winn, D. M., Herrero, R., Franceschi, S., Castellsague, X., Muscat, J., Morgenstern, H., … Boccia, S. (2014). Adult height and head and neck cancer: A pooled analysis within the INHANCE Consortium. Head Neck, 36(10), 1391.
Lopes, N. B., Silva, L. A. F., Samelli, A. G., & Matas, C. G. (2020). Effects of chemotherapy on the auditory system of children with cancer: a systematic literature review. Rev CEFAC, 22(2),e13919.
Mujica-Mota, M., Waissbluth, S., & Daniel, S. J. (2013). Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: A systematic review. Head Neck, 35(11), 1662–1668.
Nichols, A. C., Theurer, J., Prisman, E., Read, N., Berthelet, E., Tran, E., Fung, K., de Almeida, J. R., Bayley, A., Goldstein, D. P., Hier, M., Sultanem, K., Richardson, K., Mlynarek, A., Krishnan, S., Le, H., Yoo, J., MacNeil, S. D., Winquist, E., … Palma, D. A. (2019). Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. Lancet Oncol, 20(10), 1349–1359.
Pignon, J. P., Maître, A. le, Maillard, E., & Bourhis, J. (2009). Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiot Oncol, 92(1), 4–14.
Volpato, G.L. (2007). Ciência da filosofia à publicação. São Paulo: Cultura Academica.
Sham, J. S. T., & Choy, D. T. K. (1992). Early Changes Of Auditory Brain Stem Evoked Response After Radiotherapy For Nasopharyngeal Carcinoma—A Prospective Study. J Laryngol Otol, 106(10), 887–892.
Sturgis, E. M., & Ang, K. K. (2011). The epidemic of HVP-associated oropharyngeal cancer is here: Is it time to change our treatment paradigms? J Nat Comp Cancer Net, 9(6), 665–673.
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer J Clinic, 71(3), 209–249.
Tchounwou, P. B., Dasari, S., Noubissi, F. K., Ray, P., & Kumar, S. (2021). Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy. J Exp Pharmacol, 13, 303–328.
Theunissen, E. A. R., Zuur, C. L., Bosma, S. C. J., Lopez-Yurda, M., Hauptmann, M., Van Der Baan, S., De Boer, J. P., Van Der Molen, L., Rasch, C. R. N., Dreschler, W. A., & Balm, A. J. M. (2014). Long-term hearing loss after chemoradiation in patients with head and neck cancer. Laryngoscope, 124(12), 2720–2725.
Wong, K. L., Song, T. T., Wee, J., Fook-Chong, S. M. C., & De, Y. W. (2006). Sensorineural hearing loss after radiotherapy and chemoradiotherapy: A single, blinded, randomized study. J Clin Oncol, 24(12), 1904–1909. 6
Yan, K., Agrawal, N., & Gooi, Z. (2018). Head and Neck Masses. Med Clin North America, 102(6), 1013–1025.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Priscila Feliciano de Oliveira; Amanda Souza de Jesus ; Lucas Araujo Reis; Tamara Figueiredo do Carmo Santos; Gregorina Silva Ribeiro Rocha; Aline Cabral de Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
